Sontuzumab (AS1402) is a humanizedised IgG1kappa MUC1 specific monoclonal antibody. Sontuzumab binds the extracellular MUC1 peptide sequence PDTR with a Kd of ~1 nM. Sontuzumab can be used for the research of breast cancer[1].
Molecular Weight:
(145.38 kDa)
Purity:
99.66
CAS Number:
[372075-37-1]
Target:
Mucin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
